SLC31A1 and non-small cell lung carcinoma: The results indicated that the combined diagnosis of anti-COPT1-IgG and anti-COPT1-IgM autoantibodies can improve the diagnostic value (AUC=0.784, 95% CI: 0.736-0.833) for distinguishing NSCLC from NC (Figure 10A).